Copyright Reports & Markets. All rights reserved.

Global Immunotoxins Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Immunotoxins Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Immunotoxins Market Size Growth Rate by Product
      • 1.4.2 Anthrax Based Toxins
      • 1.4.3 Diphtheria Toxin (DT) & DT Derivatives
      • 1.4.4 Pseudomonas Exotoxin (PE) & PE Derivatives
      • 1.4.5 Ribosome Inactivating Proteins Based Immunotoxins
      • 1.4.6 Ribonucleases based Immunotoxins
      • 1.4.7 Others
    • 1.5 Market by End User
      • 1.5.1 Global Immunotoxins Market Size Growth Rate by End User
      • 1.5.2 Solid Tumors
      • 1.5.3 Leukemias
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Immunotoxins Market Size
      • 2.1.1 Global Immunotoxins Revenue 2014-2025
      • 2.1.2 Global Immunotoxins Sales 2014-2025
    • 2.2 Immunotoxins Growth Rate by Regions
      • 2.2.1 Global Immunotoxins Sales by Regions
      • 2.2.2 Global Immunotoxins Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Immunotoxins Sales by Manufacturers
      • 3.1.1 Immunotoxins Sales by Manufacturers
      • 3.1.2 Immunotoxins Sales Market Share by Manufacturers
      • 3.1.3 Global Immunotoxins Market Concentration Ratio (CR5 and HHI)
    • 3.2 Immunotoxins Revenue by Manufacturers
      • 3.2.1 Immunotoxins Revenue by Manufacturers (2014-2019)
      • 3.2.2 Immunotoxins Revenue Share by Manufacturers (2014-2019)
    • 3.3 Immunotoxins Price by Manufacturers
    • 3.4 Immunotoxins Manufacturing Base Distribution, Product Types
      • 3.4.1 Immunotoxins Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Immunotoxins Product Type
      • 3.4.3 Date of International Manufacturers Enter into Immunotoxins Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Immunotoxins Sales by Product
    • 4.2 Global Immunotoxins Revenue by Product
    • 4.3 Immunotoxins Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Immunotoxins Breakdown Data by End User

    6 North America

    • 6.1 North America Immunotoxins by Countries
      • 6.1.1 North America Immunotoxins Sales by Countries
      • 6.1.2 North America Immunotoxins Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Immunotoxins by Product
    • 6.3 North America Immunotoxins by End User

    7 Europe

    • 7.1 Europe Immunotoxins by Countries
      • 7.1.1 Europe Immunotoxins Sales by Countries
      • 7.1.2 Europe Immunotoxins Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Immunotoxins by Product
    • 7.3 Europe Immunotoxins by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Immunotoxins by Countries
      • 8.1.1 Asia Pacific Immunotoxins Sales by Countries
      • 8.1.2 Asia Pacific Immunotoxins Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Immunotoxins by Product
    • 8.3 Asia Pacific Immunotoxins by End User

    9 Central & South America

    • 9.1 Central & South America Immunotoxins by Countries
      • 9.1.1 Central & South America Immunotoxins Sales by Countries
      • 9.1.2 Central & South America Immunotoxins Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Immunotoxins by Product
    • 9.3 Central & South America Immunotoxins by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Immunotoxins by Countries
      • 10.1.1 Middle East and Africa Immunotoxins Sales by Countries
      • 10.1.2 Middle East and Africa Immunotoxins Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Immunotoxins by Product
    • 10.3 Middle East and Africa Immunotoxins by End User

    11 Company Profiles

    • 11.1 Biotest
      • 11.1.1 Biotest Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Biotest Immunotoxins Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Biotest Immunotoxins Products Offered
      • 11.1.5 Biotest Recent Development
    • 11.2 Celldex Therapeutics
      • 11.2.1 Celldex Therapeutics Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Celldex Therapeutics Immunotoxins Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Celldex Therapeutics Immunotoxins Products Offered
      • 11.2.5 Celldex Therapeutics Recent Development
    • 11.3 Amgen
      • 11.3.1 Amgen Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Amgen Immunotoxins Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Amgen Immunotoxins Products Offered
      • 11.3.5 Amgen Recent Development
    • 11.4 Genmab
      • 11.4.1 Genmab Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Genmab Immunotoxins Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Genmab Immunotoxins Products Offered
      • 11.4.5 Genmab Recent Development
    • 11.5 AREVA Med
      • 11.5.1 AREVA Med Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 AREVA Med Immunotoxins Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 AREVA Med Immunotoxins Products Offered
      • 11.5.5 AREVA Med Recent Development
    • 11.6 Bayer HealthCare
      • 11.6.1 Bayer HealthCare Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Bayer HealthCare Immunotoxins Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Bayer HealthCare Immunotoxins Products Offered
      • 11.6.5 Bayer HealthCare Recent Development
    • 11.7 Neurocrine Biosciences
      • 11.7.1 Neurocrine Biosciences Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Neurocrine Biosciences Immunotoxins Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Neurocrine Biosciences Immunotoxins Products Offered
      • 11.7.5 Neurocrine Biosciences Recent Development
    • 11.8 Research Corporation Technologies
      • 11.8.1 Research Corporation Technologies Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Research Corporation Technologies Immunotoxins Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Research Corporation Technologies Immunotoxins Products Offered
      • 11.8.5 Research Corporation Technologies Recent Development
    • 11.9 CuraGen Corporation
      • 11.9.1 CuraGen Corporation Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 CuraGen Corporation Immunotoxins Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 CuraGen Corporation Immunotoxins Products Offered
      • 11.9.5 CuraGen Corporation Recent Development
    • 11.10 Genentech
      • 11.10.1 Genentech Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Genentech Immunotoxins Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Genentech Immunotoxins Products Offered
      • 11.10.5 Genentech Recent Development

    12 Future Forecast

    • 12.1 Immunotoxins Market Forecast by Regions
      • 12.1.1 Global Immunotoxins Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Immunotoxins Revenue Forecast by Regions 2019-2025
    • 12.2 Immunotoxins Market Forecast by Product
      • 12.2.1 Global Immunotoxins Sales Forecast by Product 2019-2025
      • 12.2.2 Global Immunotoxins Revenue Forecast by Product 2019-2025
    • 12.3 Immunotoxins Market Forecast by End User
    • 12.4 North America Immunotoxins Forecast
    • 12.5 Europe Immunotoxins Forecast
    • 12.6 Asia Pacific Immunotoxins Forecast
    • 12.7 Central & South America Immunotoxins Forecast
    • 12.8 Middle East and Africa Immunotoxins Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Immunotoxins Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Immunotoxins market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Immunotoxins market based on company, product type, end user and key regions.

      This report studies the global market size of Immunotoxins in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Immunotoxins in these regions.
      This research report categorizes the global Immunotoxins market by top players/brands, region, type and end user. This report also studies the global Immunotoxins market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Biotest
      Celldex Therapeutics
      Amgen
      Genmab
      AREVA Med
      Bayer HealthCare
      Neurocrine Biosciences
      Research Corporation Technologies
      CuraGen Corporation
      Genentech

      Market size by Product
      Anthrax Based Toxins
      Diphtheria Toxin (DT) & DT Derivatives
      Pseudomonas Exotoxin (PE) & PE Derivatives
      Ribosome Inactivating Proteins Based Immunotoxins
      Ribonucleases based Immunotoxins
      Others
      Market size by End User
      Solid Tumors
      Leukemias

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Immunotoxins market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Immunotoxins market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Immunotoxins companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Immunotoxins submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Immunotoxins are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Immunotoxins market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now